Cytek Biosciences, Inc. CTKB Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Cytek Biosciences, Inc.’s reported figures.
The official record: Cytek Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytek Biosciences, Inc.'s enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cytek Biosciences, Inc.'s enterprise value?
- Cytek Biosciences, Inc. (CTKB) reported enterprise value of $546.73M in Q1 2026.
- How has Cytek Biosciences, Inc.'s enterprise value changed year-over-year?
- Cytek Biosciences, Inc.'s enterprise value increased by 27.1% year-over-year, from $430.28M to $546.73M.
- What is the long-term trend for Cytek Biosciences, Inc.'s enterprise value?
- Over 4 years (2021 to 2025), Cytek Biosciences, Inc.'s enterprise value has grown at a -23.3% compound annual growth rate (CAGR), from $1.84B to $634.18M.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.